Pfizer’s Animal Health unit has signed an exclusive deal with the American Kennel Club’s Canine Health Foundation (CHF)—the largest nonprofit worldwide—to fund health research exclusively for canines.
This new research partnership names Pfizer Animal Health the sole biopharmaceutical partner of CHF, and begins with Pfizer committing to provide an initial $50,000 over a two-year period.
According to Market Watch, the collaboration will focus on basic and applied research initiatives and on sharing leadership and scientific expertise.
As part of Pfizer Animal Health’s commitment to veterinarians, the research will focus on future discoveries in canine nutrition, genetics, and disease, “and how this supports veterinarians, the animals they care for and their owners,” according to the press release from Pfizer.
“We have the opportunity to gain enormous insights and be a part of pursuing scientific discoveries that not only impact animals, but also may involve translational medicine that impacts humans,” said David Haworth, DVM, PhD, director of Global Alliances for Pfizer Animal Health in a statement.